SEC Form 4 · accession 0001102624-15-000851
Boston Therapeutics, Inc. · BTHE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Platt
Officer — CEO and Chairman · Director · 10% Owner
Period of report
May 14, 2015
Accepted (ET)
May 18, 2015 · 1:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001473579
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 14, 2015 | P | 5,000 | $0.12 | A | 7,560,985 | D | |
| Common Stock | May 15, 2015 | P | 1,000 | $0.1476 | A | 7,561,985 | D |
Table II — derivative securities
No Table II lines on this filing.